The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Pseudomonas Aeruginosa Biofilms in Cystic fibrosis
Abstract
The persistence of chronic Pseudomonas aeruginosa lung infections in cystic fibrosis (CF) patients is due to biofilm-growing mucoid (alginate-producing) strains. A biofilm is a structured consortium of bacteria, embedded in a self-produced polymer matrix consisting of polysaccharide, protein and DNA. In CF lungs, the polysaccharide alginate is the major part of the P. aeruginosa biofilm matrix. Bacterial biofilms cause chronic infections because they show increased tolerance to antibiotics and resist phagocytosis, as well as other components of the innate and the adaptive immune system. As a consequence, a pronounced antibody response develops, leading to immune complex-mediated chronic inflammation, dominated by polymorphonuclear leukocytes. The chronic inflammation is the major cause of the lung tissue damage in CF. Biofilm growth in CF lungs is associated with an increased frequency of mutations, slow growth and adaptation of the bacteria to the conditions in the lungs, and to antibiotic therapy. Low bacterial metabolic activity and increase of doubling times of the bacterial cells in CF lungs are responsible for some of the tolerance to antibiotics. Conventional resistance mechanisms, such as chromosomal β-lactamase, upregulated efflux pumps, and mutations of antibiotic target molecules in the bacteria, also contribute to the survival of P. aeruginosa biofilms. Biofilms can be prevented by early aggressive antibiotic prophylaxis or therapy, and they can be treated by chronic suppressive therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen
Stover, C. K., Pham, X. Q., Erwin, A. L., Mizoguchi, S. D., Warrener, P., Hickey, M. J., Brinkman, F. S. L., Hufnagle, W. O., Kowalik, D. J., Lagrou, M., et al. (2000) · Nature · doi:10.1038/35023079 · Cited by 4,573
Antibiotic resistance of bacterial biofilms
Høiby, N., Bjarnsholt, T., Givskov, M., Molin, S., & Ciofu, O. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.12.011 · Cited by 3,225
Self-citationHigh Frequency of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Lung Infection
Oliver, A., Cantón, R., Campo, P., Baquero, F., & Blázquez, J. (2000) · Science · doi:10.1126/science.288.5469.1251 · Cited by 1,465
Adaptive radiation in a heterogeneous environment
Rainey, P. B., & Travisano, M. (1998) · Nature · doi:10.1038/27900 · Cited by 1,306
Intermittent Administration of Inhaled Tobramycin in Patients with Cystic Fibrosis
Ramsey, B. W., Pepe, M. S., Quan, J. M., Otto, K. L., Montgomery, A. B., Williams-Warren, J., Vasiljev-K, M., Borowitz, D., Bowman, C. M., Marshall, B. C., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400104 · Cited by 1,300
Persister cells and tolerance to antimicrobials
Keren, I., Kaldalu, N., Spoering, A., Wang, Y., & Lewis, K. (2004) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(03)00856-5 · Cited by 1,098
Worlitzsch, D., Tarran, R., Ulrich, M., Schwab, U., Cekici, A., Meyer, K. C., Birrer, P., Bellon, G., Berger, J., Weiss, T., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213870 · Cited by 932
Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients
Bjarnsholt, T., Jensen, P. Ø., Fiandaca, M. J., Pedersen, J., Hansen, C. R., Andersen, C. B., Pressler, T., Givskov, M., & Høiby, N. (2009) · Pediatric Pulmonology · doi:10.1002/ppul.21011 · Cited by 795
Self-citationNew concepts of the pathogenesis of cystic fibrosis lung disease
Boucher, R. C. (2004) · European Respiratory Journal · doi:10.1183/09031936.03.00057003 · Cited by 640
Screening for Quorum-Sensing Inhibitors (QSI) by Use of a Novel Genetic System, the QSI Selector
Rasmussen, T. B., Bjarnsholt, T., Skindersoe, M. E., Hentzer, M., Kristoffersen, P., Köte, M., Nielsen, J., Eberl, L., & Givskov, M. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.5.1799-1814.2005 · Cited by 622
Self-citation
Cited by
Bacterial Biofilm and its Role in the Pathogenesis of Disease
Vestby, L. K., Grønseth, T., Simm, R., & Nesse, L. L. (2020) · Antibiotics · doi:10.3390/antibiotics9020059 · Cited by 1,105
Sharma, S., Mohler, J., Mahajan, S. D., Schwartz, S. A., Bruggemann, L., & Aalinkeel, R. (2023) · Microorganisms · doi:10.3390/microorganisms11061614 · Cited by 993
Strategies for combating bacterial biofilm infections
Wu, H., Moser, C., Wang, H.-Z., Høiby, N., & Song, Z.-J. (2015) · International Journal of Oral Science · doi:10.1038/ijos.2014.65 · Cited by 925
Self-citationThe clinical impact of bacterial biofilms
Høiby, N., Ciofu, O., Johansen, H. K., Song, Z., Moser, C., Jensen, P. Ø., Molin, S., Givskov, M., Tolker‐Nielsen, T., & Bjarnsholt, T. (2011) · International Journal of Oral Science · doi:10.4248/ijos11026 · Cited by 894
Self-citationBiofilm infections, their resilience to therapy and innovative treatment strategies
Römling, U., & Balsalobre, C. (2012) · Journal of Internal Medicine · doi:10.1111/joim.12004 · Cited by 865
de la Fuente-Núñez, C., Reffuveille, F., Fernández, L., & Hancock, R. E. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.06.013 · Cited by 801
Healthcare-associated infections, medical devices and biofilms: risk, tolerance and control
Percival, S. L., Suleman, L., Vuotto, C., & Donelli, G. (2015) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000032 · Cited by 736
Horizontal Gene Exchange in Environmental Microbiota
Aminov, R. I. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00158 · Cited by 644
Biofilm dispersion and quorum sensing
Solano, C., Echeverz, M., & Lasa, I. (2014) · Current Opinion in Microbiology · doi:10.1016/j.mib.2014.02.008 · Cited by 634
Bacterial Metabolism and Antibiotic Efficacy
Stokes, J. M., Lopatkin, A. J., Lobritz, M. A., & Collins, J. J. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.06.009 · Cited by 617
Otto, M. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-042711-140023 · Cited by 606
Rasamiravaka, T., Labtani, Q., Duez, P., & El Jaziri, M. (2015) · BioMed Research International · doi:10.1155/2015/759348 · Cited by 546
From in vitro to in vivo Models of Bacterial Biofilm-Related Infections
Lebeaux, D., Chauhan, A., Rendueles, O., & Beloin, C. (2013) · Pathogens · doi:10.3390/pathogens2020288 · Cited by 545
Role of Exopolysaccharides in Pseudomonas aeruginosa Biofilm Formation and Architecture
Ghafoor, A., Hay, I. D., & Rehm, B. H. A. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.00637-11 · Cited by 524
Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface
Malhotra, S., Hayes, D., & Wozniak, D. J. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00138-18 · Cited by 515
Treatment of lung infection in patients with cystic fibrosis: Current and future strategies
Döring, G., Flume, P., Heijerman, H., & Elborn, J. S. (2012) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2012.10.004 · Cited by 474
Bacterial Contribution in Chronicity of Wounds
Rahim, K., Saleha, S., Zhu, X., Huo, L., Basit, A., & Franco, O. L. (2017) · Microbial Ecology · doi:10.1007/s00248-016-0867-9 · Cited by 443
Molecular Basis of In Vivo Biofilm Formation by Bacterial Pathogens
Joo, H.-S., & Otto, M. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.10.022 · Cited by 434
Chua, S. L., Liu, Y., Yam, J. K. H., Chen, Y., Vejborg, R. M., Tan, B. G. C., Kjelleberg, S., Tolker-Nielsen, T., Givskov, M., & Yang, L. (2014) · Nature Communications · doi:10.1038/ncomms5462 · Cited by 421
Biofilms: Understanding the structure and contribution towards bacterial resistance in antibiotics
Shree, P., Singh, C. K., Sodhi, K. K., Surya, J. N., & Singh, D. K. (2023) · Medicine in Microecology · doi:10.1016/j.medmic.2023.100084 · Cited by 396
Synergy and Order Effects of Antibiotics and Phages in Killing Pseudomonas aeruginosa Biofilms
Chaudhry, W. N., Concepción-Acevedo, J., Park, T., Andleeb, S., Bull, J. J., & Levin, B. R. (2017) · PLOS ONE · doi:10.1371/journal.pone.0168615 · Cited by 394
Updates on the pathogenicity status of Pseudomonas aeruginosa
Azam, M. W., & Khan, A. U. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2018.07.003 · Cited by 374
Towards diagnostic guidelines for biofilm-associated infections
Hall-Stoodley, L., Stoodley, P., Kathju, S., Høiby, N., Moser, C., William Costerton, J., Moter, A., & Bjarnsholt, T. (2012) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2012.00968.x · Cited by 357
Self-citationSolutions to the Public Goods Dilemma in Bacterial Biofilms
Drescher, K., Nadell, C. D., Stone, H. A., Wingreen, N. S., & Bassler, B. L. (2014) · Current Biology · doi:10.1016/j.cub.2013.10.030 · Cited by 354
Biofilms in Periprosthetic Orthopedic Infections
McConoughey, S. J., Howlin, R., Granger, J. F., Manring, M. M., Calhoun, J. H., Shirtliff, M., Kathju, S., & Stoodley, P. (2014) · Future Microbiology · doi:10.2217/fmb.14.64 · Cited by 343
Biofilms: Formation, drug resistance and alternatives to conventional approaches
Mirghani, R., Saba, T., Khaliq, H., Mitchell, J., Do, L., Chambi, L., Diaz, K., Kennedy, T., Alkassab, K., Huynh, T., et al. (2022) · AIMS Microbiology · doi:10.3934/microbiol.2022019 · Cited by 333
Filamentous Bacteriophage Promote Biofilm Assembly and Function
Secor, P. R., Sweere, J. M., Michaels, L. A., Malkovskiy, A. V., Lazzareschi, D., Katznelson, E., Rajadas, J., Birnbaum, M. E., Arrigoni, A., Braun, K. R., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.10.013 · Cited by 331
Ciofu, O., Tolker-Nielsen, T., Jensen, P. Ø., Wang, H., & Høiby, N. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.11.017 · Cited by 306
Self-citationRegulation of biofilm formation in P seudomonas and B urkholderia species
Fazli, M., Almblad, H., Rybtke, M. L., Givskov, M., Eberl, L., & Tolker‐Nielsen, T. (2014) · Environmental Microbiology · doi:10.1111/1462-2920.12448 · Cited by 306
Pyocyanin effects on respiratory epithelium: relevance in Pseudomonas aeruginosa airway infections
Rada, B., & Leto, T. L. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2012.10.004 · Cited by 302
Control of Biofilm Formation: Antibiotics and Beyond
Algburi, A., Comito, N., Kashtanov, D., Dicks, L. M. T., & Chikindas, M. L. (2017) · Applied and Environmental Microbiology · doi:10.1128/aem.02508-16 · Cited by 299
Genetic and Functional Diversity of Pseudomonas aeruginosa Lipopolysaccharide
Lam, J. S., Taylor, V. L., Islam, S. T., Hao, Y., & Kocíncová, D. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00118 · Cited by 298
Fluorescence-Based Reporter for Gauging Cyclic Di-GMP Levels in Pseudomonas aeruginosa
Rybtke, M. T., Borlee, B. R., Murakami, K., Irie, Y., Hentzer, M., Nielsen, T. E., Givskov, M., Parsek, M. R., & Tolker-Nielsen, T. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.00414-12 · Cited by 287
Managing Cystic Fibrosis: Strategies That Increase Life Expectancy and Improve Quality of Life
Cohen-Cymberknoh, M., Shoseyov, D., & Kerem, E. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201009-1478ci · Cited by 287
Sousa, A., & Pereira, M. (2014) · Pathogens · doi:10.3390/pathogens3030680 · Cited by 279
Lahiri, D., Nag, M., Sheikh, H. I., Sarkar, T., Edinur, H. A., Pati, S., & Ray, R. R. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.636588 · Cited by 279
Falkinham, J. O., Hilborn, E. D., Arduino, M. J., Pruden, A., & Edwards, M. A. (2015) · Environmental Health Perspectives · doi:10.1289/ehp.1408692 · Cited by 277
Schulze, A., Mitterer, F., Pombo, J. P., & Schild, S. (2021) · Microbial Cell · doi:10.15698/mic2021.02.741 · Cited by 275
Cell-surface signaling in Pseudomonas: stress responses, iron transport, and pathogenicity
Llamas, M. A., Imperi, F., Visca, P., & Lamont, I. L. (2014) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12078 · Cited by 176
Deppisch, C., Herrmann, G., Graepler-Mainka, U., Wirtz, H., Heyder, S., Engel, C., Marschal, M., Miller, C. C., & Riethmüller, J. (2016) · Infection · doi:10.1007/s15010-016-0879-x · Cited by 115
Recent developments in the use of nanoparticles for treatment of biofilms
Han, C., Romero, N., Fischer, S., Dookran, J., Berger, A., & Doiron, A. L. (2017) · Nanotechnology Reviews · doi:10.1515/ntrev-2016-0054 · Cited by 114
Gamma-aminobutyric acid acts as a specific virulence regulator in Pseudomonas aeruginosa
Dagorn, A., Hillion, M., Chapalain, A., Lesouhaitier, O., Duclairoir Poc, C., Vieillard, J., Chevalier, S., Taupin, L., Le Derf, F., & Feuilloley, M. G. J. (2013) · Microbiology · doi:10.1099/mic.0.061267-0 · Cited by 51
Reighard, K. P., & Schoenfisch, M. H. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01208-15 · Cited by 49
Borrelia burgdorferi Co-Localizing with Amyloid Markers in Alzheimer’s Disease Brain Tissues
Senejani, A. G., Maghsoudlou, J., El-Zohiry, D., Gaur, G., Wawrzeniak, K., Caravaglia, C., Khatri, V. A., MacDonald, A., & Sapi, E. (2022) · Journal of Alzheimer's Disease · doi:10.3233/jad-215398 · Cited by 40
Zygiel, E. M., Obisesan, A. O., Nelson, C. E., Oglesby, A. G., & Nolan, E. M. (2021) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.015975 · Cited by 36
Holzinger, J. M., Toelge, M., Werner, M., Ederer, K. U., Siegmund, H. I., Peterhoff, D., Blaas, S. H., Gisch, N., Brochhausen, C., Gessner, A., et al. (2023) · eLife · doi:10.7554/elife.86369 · Cited by 4
Anderson, C. M., Mattenberger, Y., Parga, A., Portalier, H., Tan, C. A. Z., Esteban Henao, M., Viollier, P. H., & Kline, K. A. (2026) · Journal of Bacteriology · doi:10.1128/jb.00548-25 · Cited by 2
Metadata
- Authors
- H⊘iby, N., Ciofu, O., & Bjarnsholt, T.
- Venue
- Future Microbiology
- Publisher
- Informa UK Limited
- Published
- 2010-11
- Volume
- 5
- Issue
- 11
- Pages
- 1663-1674
- ISSN
- 1746-0913 (ISSN-L)
- 1746-0921
- OpenAlex
- W2149908911
- Cited by
- 666
- References
- 91
- FWCI
- 8.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.